142 related articles for article (PubMed ID: 12830322)
1. Development of NF2 gene specific, strictly sequence defined diagnostic microarray for deletion detection.
Mantripragada KK; Buckley PG; Jarbo C; Menzel U; Dumanski JP
J Mol Med (Berl); 2003 Jul; 81(7):443-51. PubMed ID: 12830322
[TBL] [Abstract][Full Text] [Related]
2. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH.
Bruder CE; Hirvelä C; Tapia-Paez I; Fransson I; Segraves R; Hamilton G; Zhang XX; Evans DG; Wallace AJ; Baser ME; Zucman-Rossi J; Hergersberg M; Boltshauser E; Papi L; Rouleau GA; Poptodorov G; Jordanova A; Rask-Andersen H; Kluwe L; Mautner V; Sainio M; Hung G; Mathiesen T; Möller C; Pulst SM; Harder H; Heiberg A; Honda M; Niimura M; Sahlén S; Blennow E; Albertson DG; Pinkel D; Dumanski JP
Hum Mol Genet; 2001 Feb; 10(3):271-82. PubMed ID: 11159946
[TBL] [Abstract][Full Text] [Related]
3. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
Buckley PG; Mantripragada KK; Díaz de Ståhl T; Piotrowski A; Hansson CM; Kiss H; Vetrie D; Ernberg IT; Nordenskjöld M; Bolund L; Sainio M; Rouleau GA; Niimura M; Wallace AJ; Evans DG; Grigelionis G; Menzel U; Dumanski JP
Hum Mutat; 2005 Dec; 26(6):540-9. PubMed ID: 16287142
[TBL] [Abstract][Full Text] [Related]
4. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
[TBL] [Abstract][Full Text] [Related]
5. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
[TBL] [Abstract][Full Text] [Related]
6. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
Diebold R; Bartelt-Kirbach B; Evans DG; Kaufmann D; Hanemann CO
J Mol Diagn; 2005 Feb; 7(1):97-104. PubMed ID: 15681480
[TBL] [Abstract][Full Text] [Related]
7. NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH.
Szijan I; Rochefort D; Bruder C; Surace E; Machiavelli G; Dalamon V; Cotignola J; Ferreiro V; Campero A; Basso A; Dumanski JP; Rouleau GA
Neuromolecular Med; 2003; 3(1):41-52. PubMed ID: 12665675
[TBL] [Abstract][Full Text] [Related]
8. DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree.
MacCollin M; Mohney T; Trofatter J; Wertelecki W; Ramesh V; Gusella J
JAMA; 1993 Nov; 270(19):2316-20. PubMed ID: 8230593
[TBL] [Abstract][Full Text] [Related]
9. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
11. Detection of copy number changes at the NF1 locus with improved high-resolution array CGH.
Shen MH; Mantripragada K; Dumanski JP; Frayling I; Upadhyaya M
Clin Genet; 2007 Sep; 72(3):238-44. PubMed ID: 17718862
[TBL] [Abstract][Full Text] [Related]
12. Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.
Wallace AJ; Watson CJ; Oward E; Evans DG; Elles RG
Genet Test; 2004; 8(4):368-80. PubMed ID: 15684865
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of germline NF2 gene rearrangements.
Legoix P; Sarkissian HD; Cazes L; Giraud S; Sor F; Rouleau GA; Lenoir G; Thomas G; Zucman-Rossi J
Genomics; 2000 Apr; 65(1):62-6. PubMed ID: 10777666
[TBL] [Abstract][Full Text] [Related]
14. A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications.
Buckley PG; Mantripragada KK; Benetkiewicz M; Tapia-Páez I; Diaz De Ståhl T; Rosenquist M; Ali H; Jarbo C; De Bustos C; Hirvelä C; Sinder Wilén B; Fransson I; Thyr C; Johnsson BI; Bruder CE; Menzel U; Hergersberg M; Mandahl N; Blennow E; Wedell A; Beare DM; Collins JE; Dunham I; Albertson D; Pinkel D; Bastian BC; Faruqi AF; Lasken RS; Ichimura K; Collins VP; Dumanski JP
Hum Mol Genet; 2002 Dec; 11(25):3221-9. PubMed ID: 12444106
[TBL] [Abstract][Full Text] [Related]
15. DNA copy-number analysis of the 22q11 deletion-syndrome region using array-CGH with genomic and PCR-based targets.
Mantripragada KK; Tapia-Páez I; Blennow E; Nilsson P; Wedell A; Dumanski JP
Int J Mol Med; 2004 Feb; 13(2):273-9. PubMed ID: 14719134
[TBL] [Abstract][Full Text] [Related]
16. Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature.
Davidson TB; Sanchez-Lara PA; Randolph LM; Krieger MD; Wu SQ; Panigrahy A; Shimada H; Erdreich-Epstein A
BMC Med Genet; 2012 Mar; 13():19. PubMed ID: 22436304
[TBL] [Abstract][Full Text] [Related]
17. Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.
Castellanos E; Bielsa I; Carrato C; Rosas I; Solanes A; Hostalot C; Amilibia E; Prades J; Roca-Ribas F; Lázaro C; Blanco I; Serra E;
BMC Med Genomics; 2015 Jan; 8():2. PubMed ID: 25739810
[TBL] [Abstract][Full Text] [Related]
18. The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases.
Lasota J; Fetsch JF; Wozniak A; Wasag B; Sciot R; Miettinen M
Am J Pathol; 2001 Apr; 158(4):1223-9. PubMed ID: 11290539
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the translocation breakpoint on chromosome 22q12.2 in a patient with neurofibromatosis type 2 (NF2).
Arai E; Ikeuchi T; Nakamura Y
Hum Mol Genet; 1994 Jun; 3(6):937-9. PubMed ID: 7951241
[TBL] [Abstract][Full Text] [Related]
20. [Development and establishment of a yeast-based stop codon assay for detection of NF2 gene premature-terminating mutations].
Kobayashi H
Hokkaido Igaku Zasshi; 1999 Sep; 74(5):377-86. PubMed ID: 10495852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
